AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).

Biotechnology

AltPep

AltPep's headquarters in Seattle, WA, United States

Valerie Daggett

Amy C.

Nancy Hill

Gil Block

Charles Horne

Kurt Becker

Patrik Edenholm

Michael Levitt

David Goel

Alan Fersht

Jeff Roh

Joel S. Marcus

Todd Patrick

Chad Robins

Roger Armen

The Advisory Team at AltPep plays a critical role in guiding the company’s strategic direction and enhancing its scientific and business initiatives. Comprised of seasoned experts and board members, the team provides invaluable insights on research advancements, regulatory pathways, and market trends, ensuring that AltPep's innovative approaches to diagnosing and treating Alzheimer’s Disease are effectively aligned with industry standards and opportunities for growth.

Advisory Team

This department focuses on the innovation and advancement of scientific knowledge through research and experimentation.

Research and Development

This department focuses on managing and optimizing organizational processes and resources to enhance overall efficiency.

Business Operations

This department provides strategic direction and oversight for the organization's overall operations and governance.

Executive Leadership

The Leadership Team at AltPep Corporation guides the strategic direction and operational execution of the company’s mission to revolutionize the diagnosis and treatment of amyloid diseases. Comprised of top executives including the CEO, CFO, CMO, and other key leaders, this team drives innovation, ensures regulatory compliance, secures funding, and cultivates business partnerships to advance the development of their groundbreaking therapies for Alzheimer's Disease and other CNS disorders. Through collaboration and foresight, they strive to position AltPep as a leader in the biomedical field.

Leadership Team

The Scientific Research Team at AltPep is dedicated to advancing the understanding and treatment of amyloid diseases, particularly Alzheimer’s Disease. Comprised of experts including medical laboratory scientists and senior researchers, the team conducts cutting-edge experiments to identify and neutralize toxic oligomers associated with these disorders, driving the development of innovative diagnostic and therapeutic solutions. Their collaborative efforts in drug discovery and development aim to translate scientific breakthroughs into transformative treatments for patients.

AltPep

Org chart

Board & advisors

Teams

Advisory Team

Research and Development

Business Operations

Executive Leadership

Leadership Team

Scientific Research Team

Offices

AltPep

Org chart

Board & advisors

Teams

Advisory Team

Research and Development

Business Operations

Executive Leadership

Leadership Team

Scientific Research Team

Offices

Related companies